Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders
Ramya Ramaswami(National Cancer Institute), Robert Yarchoan(National Cancer Institute), Kathryn Lurain(The Ohio State University), Joseph M. Ziegelbauer(National Institutes of Health), Armando Filie(National Institutes of Health), Nazzarena Labò(Frederick National Laboratory for Cancer Research), Denise Whitby(Frederick National Laboratory for Cancer Research), Wendell Miley(Frederick National Laboratory for Cancer Research), Thomas S. Uldrick(Regeneron (United States)), Vickie Marshall(Leidos (United States)), Maryalice Stetler‐Stevenson(National Cancer Institute), Anaida Widell(AIDS United), Matthew Lindsley(Center for Cancer Research), Elena Cornejo-Castro(Frederick National Laboratory for Cancer Research), Adam Rupert(Frederick National Laboratory for Cancer Research), Hao‐Wei Wang(Fu Jen Catholic University), Constance M. Yuan(National Cancer Institute)
Cited by 10
Related Papers
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422